Home > Analytics > ASTRAZENECA PHARMA INDIA

ASTRAZENECA PHARMA INDIA
Intrinsic Value | Fundamental Analysis

BOM : 506820     NSE : ASTRAZEN    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Jun 24,2022
Price(EOD): β‚Ή 2,731.55
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: β‚Ή 6,828.88 Cr
Value of β‚Ή 1 Lac invested in ASTRAZENECA PHARMA INDIA
on Jun 27,2017 (price: β‚Ή 916.70)

β‚Ή 1 L

β‚Ή 2.98 L

1W : 2% 1M : 3.1% 1Y : -25.4%
COMMUNITY POLL
for ASTRAZENECA PHARMA INDIA
Please provide your vote to see the results
ASTRAZENECA PHARMA INDIA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
ASTRAZENECA PHARMA INDIA 2% 3.1% -25.4%
SUN PHARMACEUTICAL INDUSTRIES 2.4% -8.5% 23.8%
DIVIS LABORATORIES 4.3% 6.7% -12.6%
DR REDDYS LABORATORIES 3.8% 0% -18.7%
CIPLA 0.8% -3.2% -2.4%
GLAND PHARMA 2.4% -7.3% -17.9%
PIRAMAL ENTERPRISES 3.9% -11% -33.4%
CADILA HEALTHCARE 5.7% -5.1% -45.1%
TORRENT PHARMACEUTICALS 4.1% -0.9% -2.5%

FUNDAMENTAL ANALYSIS OF ASTRAZENECA PHARMA INDIA

 
Fundamentals Score
[ Q(TTM): Mar2022, Y: Mar2021
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights πŸ’‘ ASTRAZEN is one of the top 18% companies with good fundamentals ! Discover More →

VALUATION OF ASTRAZENECA PHARMA INDIA

 
Valuation Score
[As on : Jun 24,2022 ]

Ratio Standalone
P/E
P/B
P/S
73.19
P/E Calculated based on EPS of 37.32
[ Mar2021 - Standalone Results ]

15.02
P/B Calculated based on Book Value of 181.83
[ Mar2021 - Standalone Results ]

8.48
P/S Calculated based on Revenues of 805.6 Cr
[ TTM - Standalone Results ]

Financial Ratios →

Insights πŸ’‘ There are potential 23% undervalued companies ! Discover More →

FAIR VALUE OF ASTRAZENECA PHARMA INDIA

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
19%
55%
56%

Insights πŸ’‘ You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF ASTRAZENECA PHARMA INDIA


Insights πŸ’‘ There are 10% companies with bullish price momentum currently! Discover More →

ASTRAZENECA PHARMA INDIA vs SENSEX


Insights πŸ’‘ You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF ASTRAZENECA PHARMA INDIA

Year Debt/Equity ratio
Standalone Consolidated
2021
2020
2019
Avg_3yrs
0
0
0
-
-
-
-
-
[Last Annual Data : Mar2021]
Financial Ratios →

PLEDGED PROMOTER SHARES OF ASTRAZENECA PHARMA INDIA

Pledged Promoter Shares
0 %
As on : Mar2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF ASTRAZENECA PHARMA INDIA

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
15.68%
158.82%
127.67%
145.04%
10.32%
-6.06%
0.52%
2.59%
QtrlyTrend
6
Latest Qtr: Mar2022
Quarterly Result Analysis →


ASTRAZENECA PHARMA INDIA related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE 3.1% -1.8% -13%
S&P BSE 500 2.5% -2% -1%
S&P BSE ALLCAP 2.5% -2% -0.8%
S&P BSE 400 MIDSMALLCAP 2% -1.6% -1.9%
S&P BSE MIDSMALLCAP 2% -1.4% -2%
S&P BSE 250 SMALLCAP 1.8% -2.5% -3.9%
S&P BSE SMALL CAP 1.6% -2.4% -1.3%
NSE Indices1W1M1Y
NIFTY 500 2.5% -2% -1%
NIFTY500 MULTICAP 50:25:25 2.3% -2% -1.3%
NIFTY MID SMALL400 2% -1.7% -1.6%
NIFTY SMALLCAP250 1.7% -2.4% -3.2%

You may also like the below Video Courses


FAQ about ASTRAZENECA PHARMA INDIA


Is ASTRAZENECA PHARMA INDIA good for long term investment?

As on Jun 24,2022, the Fundamentals of ASTRAZENECA PHARMA INDIA look Strong and hence it may be good for long term investment! See Financial Performance of ASTRAZENECA PHARMA INDIA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is ASTRAZENECA PHARMA INDIA UnderValued or OverValued?

As on Jun 24,2022, ASTRAZENECA PHARMA INDIA is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of ASTRAZENECA PHARMA INDIA ?

As on Jun 24,2022, the Intrinsic Value of ASTRAZENECA PHARMA INDIA is Rs. 1,762.02 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 2,292.38
Fair Value [Median EV / Sales Model] : Rs. 1,762.02
Fair Value [Median Price / Sales Model] : Rs. 1,746.90
Median Fair Value of ASTRAZENECA PHARMA INDIA : Rs. 1,762.02

Is ASTRAZENECA PHARMA INDIA trading at a Premium or Discount?

As on Jun 24,2022, ASTRAZENECA PHARMA INDIA is trading at a Premium of 55% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z
ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z